Jacobs Levy Equity Management
GOSS icon

Jacobs Levy Equity Management’s Gossamer Bio GOSS Stock Holding History

Jacobs Levy Equity Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
2,187,402
+492,243
+29% +$137K ﹤0.01% 866
2026
Q1 		$557K Sell
1,695,159
-482,874
-22% -$759K ﹤0.01% 806
2025
Q4 		$6.75M Buy
2,178,033
+769,915
+55% +$2.2M 0.03% 352
2025
Q3 		$3.7M Buy
1,408,118
+316,554
+29% +$698K 0.01% 481
2025
Q2 		$1.34M Buy
1,091,564
+809,300
+287% +$883K 0.01% 699
2025
Q1 		$310K Sell
282,264
-1,252,404
-82% -$1.45M ﹤0.01% 974
2024
Q4 		$1.39M Sell
1,534,668
-352,844
-19% -$302K ﹤0.01% 661
2024
Q3 		$1.86M Buy
1,887,512
+442,895
+31% +$426K 0.01% 620
2024
Q2 		$1.3M Sell
1,444,617
-189,467
-12% -$142K 0.01% 677
2024
Q1 		$1.93M Sell
1,634,084
-468,964
-22% -$516K 0.01% 604
2023
Q4 		$1.92M Buy
+2,103,048
New +$1.55M 0.01% 610
2022
Q2 		– Sell
-612,496
Closed -$5.32M – 1034
2022
Q1 		$5.32M Sell
612,496
-295,936
-33% -$2.85M 0.04% 405
2021
Q4 		$10.3M Sell
908,432
-68,931
-7% -$819K 0.07% 298
2021
Q3 		$12.3M Sell
977,363
-29,116
-3% -$268K 0.08% 261
2021
Q2 		$8.17M Sell
1,006,479
-54,075
-5% -$469K 0.06% 337
2021
Q1 		$9.81M Buy
1,060,554
+429,272
+68% +$4.33M 0.08% 297
2020
Q4 		$6.1M Sell
631,282
-15,131
-2% -$149K 0.05% 362
2020
Q3 		$8.02M Buy
646,413
+383,635
+146% +$5.09M 0.08% 254
2020
Q2 		$3.42M Buy
262,778
+170,045
+183% +$2.14M 0.04% 422
2020
Q1 		$941K Buy
92,733
+11,468
+14% +$150K 0.01% 639
2019
Q4 		$1.27M Buy
+81,265
New +$1.64M 0.01% 639

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Jacobs Levy Equity Management's GOSS Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Gossamer Bio (GOSS) stake by 29% in Q2 2026, buying an estimated $137K and bringing the position to 2,187,402 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Jacobs Levy Equity Management first reported a position in GOSS in Q4 2019 and has held it in 21 quarters since. The position peaked at $12.3M in Q3 2021. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Jacobs Levy Equity Management held 2,187,402 shares of Gossamer Bio worth $360K as of Q2 2026.
  • Jacobs Levy Equity Management bought 492,243 Gossamer Bio shares in Q2 2026, an estimated $137K.
  • Gossamer Bio made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #866 holding.
  • Jacobs Levy Equity Management first reported a position in Gossamer Bio in Q4 2019 and has held it in 21 quarters since.
  • Jacobs Levy Equity Management's Gossamer Bio position peaked at $12.3M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.